James L. Tyree - Jun 9, 2022 Form 4 Insider Report for ChemoCentryx, Inc. (CCXI)

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Stock symbol
CCXI
Transactions as of
Jun 9, 2022
Transactions value $
-$99,129
Form type
4
Date filed
6/13/2022, 06:28 PM
Previous filing
May 31, 2022
Next filing
Aug 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Sale -$97.6K -3.8K -16.54% $25.65 19.2K Jun 9, 2022 Direct F1, F2
transaction CCXI Common Stock Sale -$1.55K -59 -0.31% $26.22 19.1K Jun 9, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $25.15 to $26.13 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.